SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-23-023785
Filing Date
2023-04-07
Accepted
2023-04-07 16:21:25
Documents
1
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 6473
  Complete submission text file 0001209191-23-023785.txt   7882
Mailing Address 93 WORCESTER STREET WELLESLEY MA 02481
Business Address 570 PRESTON ST. SUITE 400 LOUISVILLE KY 40202 502-398-9250
Talaris Therapeutics, Inc. (Issuer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TALARIS THERAPEUTICS, INC. 93 WORCESTER STREET, SUITE 120 WELLESLEY MA 02481
Business Address
Ildstad Suzanne (Reporting) CIK: 0001845822 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40384 | Film No.: 23808969